Eugenol Nanoparticles Ameliorate Doxorubicin-Induced Spermatogenic Dysfunction by Inhibiting the PINK1/Parkin and BNIP3/NIX Signaling Pathways
Given their safety and efficacy, these ENPs have potential application prospects in mitigating doxorubicin-induced spermatogenic dysfunction.
Authors
- Peipei Yuan (ORCID: https://orcid.org/0000-0003-0807-0196)
- Xiaoke Zheng (ORCID: https://orcid.org/0000-0003-3671-231X)
- Yajuan Zheng
- M Wang
- Weisheng Feng (ORCID: https://orcid.org/0000-0002-5987-412X)
- Qing‐Yun Ma
- Yang Fu (ORCID: https://orcid.org/0000-0002-4430-8301)
- Lirui Zhao (ORCID: https://orcid.org/0009-0002-3519-6456)
- Xiaotian Sun (ORCID: https://orcid.org/0009-0008-4455-8897)
- Pengsheng Wang
- Yan Zhang (ORCID: https://orcid.org/0000-0002-4835-8541)
Institutions
- Henan Bioengineering Technology Research Center (CN)
- First Affiliated Hospital of Henan University (CN)
Publication Details
- Journal
- International Journal of Nanomedicine
- Published
- 2024-12-01
- DOI
- https://doi.org/10.2147/ijn.s494056
- Citations
- 6
- Primary Topic
- Histone Deacetylase Inhibitors Research
- Type
- article
- Field-Weighted Citation Impact
- 1.40